HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276)

Por Liu, Mingtao, Wang, Jennie, Liu, Paul
Publicado no J Pharm Biomed Anal (2016)

HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776)

Por Wang, Jennie, Liu, Mingtao, Yang, Chun, Wu, Xiaogang, Wang, Euphemia, Liu, Paul
Publicado no J Pharm Biomed Anal (2016)

HPLC METHOD DEVELOPMENT, VALIDATION AND IMPURITY CHARACTERIZATION FOR AN ANTITUMOR HSP90 INHIBITOR -- PU-H71 (NSC 750424)

Por Liu, Mingtao, Wang, Jennie, Wu, Xiaogang, Wang, Euphemia, Baptista, Diego, Scott, Brendan, Liu, Paul
Publicado em 2013

Aurora kinase A is a possible target of OSU-03012 to destabilize MYC family proteins

Por SILVA, ANDRES, WANG, JENNIE, LOMAHAN, SARAH, TRAN, TUAN-ANH, GRENLIN, LAURA, SUGANAMI, AKIKO, TAMURA, YUTAKA, IKEGAKI, NAOHIKO
Publicado em 2014

CHARACTERIZATION, HPLC METHOD DEVELOPMENT AND IMPURITY IDENTIFICATION FOR 3,4,3-LI(1,2-HOPO), A POTENT ACTINIDE CHELATOR FOR RADIONUCLIDE DECORPORATION

Por Liu, Mingtao, Wang, Jennie, Wu, Xiaogang, Wang, Euphemia, Abergel, Rebecca J., Shuh, David K., Raymond, Kenneth N., Liu, Paul
Publicado no J Pharm Biomed Anal (2014)